Kailera Therapeutics, Inc. (KLRA)
15.71
-0.14
(-0.88%)
USD |
NASDAQ |
Sep 03, 16:00
15.71
0.00 (0.00%)
After-Hours: 20:00
Kailera Therapeutics Cash from Investing (Quarterly) : -571.02M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -571.02M |
| Date | Value |
|---|---|
| March 31, 2026 | 22.85M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Moderna, Inc. | 329.00M |
| Revolution Medicines, Inc. | -1.659B |
| Sana Biotechnology, Inc. | -87.52M |
| Parabilis Medicines, Inc. | -34.06M |
| Arrowhead Pharmaceuticals, Inc. | 43.68M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -77.53M |
| Cash from Financing (Quarterly) | 667.03M |
| Free Cash Flow Per Share (Quarterly) | -0.5981 |
| Free Cash Flow to Equity (Quarterly) | -77.27M |
| Free Cash Flow to Firm (Quarterly) | -77.53M |